Thorium induced cytoproliferative effect in human liver cell HepG2: Role of insulin-like growth factor 1 receptor and downstream signaling

被引:20
作者
Ali, Manjoor [1 ]
Kumar, Amit [1 ]
Pandey, Badri N. [1 ]
机构
[1] Bhabha Atom Res Ctr, Radiat Biol & Hlth Sci Div, Bombay 400085, Maharashtra, India
关键词
Cytoproliferative effect; Thorium; IGF-1R; Akt and MAPK; Cyclin-E; MITOCHONDRIA; TOXICITY; TH-232;
D O I
10.1016/j.cbi.2014.01.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Thorium-232 (Th-232), a naturally-occurring actinide has gained significant attention due to its immense potential as a nuclear fuel for advanced reactors. Understanding the biological effects of Th-232 would significantly impact its efficient utilization with adequate health protection. Humans administered with Th-232 (thorotrast patients) or experimental animal models showed that liver is one of the major sites of Th-232 accumulation. Present study reports cellular effects of Th-232-nitrate in a human-derived liver cell (HepG2). Results showed that the low concentration of Th-232 (0.1-10 I'M) induced proliferation of HepG2 cells which was inhibited by the pre-treatment of cells with neutralizing antibody against insulin-like growth factor I receptor (IGF-1R). Consistently, Th-232 treatment was found to increase the phosphorylated level of IGF-1R-associated molecule, IRSI which serves to activate PI3K and MAPK signaling pathways. Pre-treatment with specific inhibitors of PI3K (LY294002) or JNK-MAPK (SP600125) significantly abrogated the cytoproliferative effect of Th-232. Immunofluorescence analysis showed increased levels of phospho-Akt and phospho-p1K, downstream kinases of IGF-1R, in Th-232-treated HepG2 cells suggesting the role of IGF-IR-mediated signaling in Th-232-stimulated cell proliferation. The cell cycle analysis showed that Th-232 increased S and G2-M cell fractions concomitant to the increase of cyclin-E level. Thus, the present investigation highlights the role of IGF-IR-mediated signaling in the cytoproliferative effect of Th-232 in human liver cells at low concentration. (c) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:29 / 35
页数:7
相关论文
共 50 条
[31]   Downregulation of miR-383 promotes glioma cell invasion by targeting insulin-like growth factor 1 receptor [J].
He, Zhanwen ;
Cen, Danyang ;
Luo, Xiangyang ;
Li, Dongfang ;
Li, Pinggan ;
Liang, Liyang ;
Meng, Zhe .
MEDICAL ONCOLOGY, 2013, 30 (02)
[32]   Knockdown of type I insulin-like growth factor receptor inhibits human colorectal cancer cell growth and downstream PI3K/Akt, WNT/β-catenin signal pathways [J].
Zhang, Qian-yun ;
Wang, Lu ;
Song, Zhi-yu ;
Qu, Xian-jun .
BIOMEDICINE & PHARMACOTHERAPY, 2015, 73 :12-18
[33]   Anticancer effect of genistein on BG-1 ovarian cancer growth induced by 17 β-estradiol or bisphenol A via the suppression of the crosstalk between estrogen receptor alpha and insulin-like growth factor-1 receptor signaling pathways [J].
Hwang, Kyung-A ;
Park, Min-Ah ;
Kang, Nam-Hee ;
Yi, Bo-Rim ;
Hyun, Sang-Hwan ;
Jeung, Eui-Bae ;
Choi, Kyung-Chul .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2013, 272 (03) :637-646
[34]   Insulin-like growth factor type 1 receptor signaling in the cells of oligodendrocyte lineage is required for normal in vivo oligodendrocyte development and myelination [J].
Zeger, Martha ;
Popken, Greg ;
Zhang, Jihui ;
Xuan, Shouhong ;
Lu, Q. Richard ;
Schwab, Markus H. ;
Nave, Klaus-Armin ;
Rowitch, David ;
D'Ercole, A. Joseph ;
Ye, Ping .
GLIA, 2007, 55 (04) :400-411
[35]   Establishing a new human lung squamous cell carcinoma cell line, OMUL-1, expressing insulin-like growth factor 1 receptor and programmed cell death ligand 1 [J].
Nagamine, Hiroaki ;
Yashiro, Masakazu ;
Mizutani, Megumi ;
Sugimoto, Akira ;
Matsumoto, Yoshiya ;
Tani, Yoko ;
Kaneda, Hiroyasu ;
Yamada, Kazuhiro ;
Watanabe, Tetsuya ;
Asai, Kazuhisa ;
Suzuki, Satoshi ;
Kawaguchi, Tomoya .
THORACIC CANCER, 2025, 16 (01)
[36]   Insulin-like growth factor-1 and myocyte growth: The danger of a dogma .2. Induced myocardial growth: Pathologic hypertrophy [J].
Anversa, P ;
Kajstura, J ;
Cheng, W ;
Reiss, K ;
Cigola, E ;
Olivetti, G .
CARDIOVASCULAR RESEARCH, 1996, 32 (03) :484-495
[37]   Inhibition of insulin-like growth factor-1 receptor enhances eribulin-induced DNA damage in colorectal cancer [J].
Yoshihiro, Tomoyasu ;
Ariyama, Hiroshi ;
Yamaguchi, Kyoko ;
Imajima, Takashi ;
Yamaga, Satoru ;
Tsuchihashi, Kenji ;
Isobe, Taichi ;
Kusaba, Hitoshi ;
Akashi, Koichi ;
Baba, Eishi .
CANCER SCIENCE, 2022, 113 (12) :4207-4218
[38]   The Synergistic Effect of Humanized Monoclonal Antibodies Targeting Insulin-Like Growth Factor 1 Receptor (IGF-1R) and Chemotherapy [J].
Sui, Ping ;
Cao, Hongxin ;
Meng, Long ;
Hu, Pingping ;
Ma, Honghai ;
Du, Jiajun .
CURRENT DRUG TARGETS, 2014, 15 (07) :674-680
[39]   Increased Insulin-Like Growth Factor 1 Receptor Protein Expression and Gene Copy Number in Small Cell Lung Cancer [J].
Badzio, Andrzej ;
Wynes, Murry W. ;
Dziadziuszko, Rafal ;
Merrick, Daniel T. ;
Pardo, Marta ;
Rzyman, Witold ;
Kowalczyk, Anna ;
Singh, Shalini ;
Ranger-Moore, James ;
Manriquez, Guadalupe ;
Gaire, Fabien ;
Jassem, Jacek ;
Hirsch, Fred R. .
JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) :1905-1911
[40]   Assessment of insulin-like growth factor 1 receptor as an oncogene in esophageal squamous cell carcinoma and its potential implication in chemotherapy [J].
Ma, Wang ;
Zhang, Tengfei ;
Pan, Jian ;
Shi, Ni ;
Fan, Qingxia ;
Wang, Liuxing ;
Lu, Shih Hsin .
ONCOLOGY REPORTS, 2014, 32 (04) :1601-1609